RVL Pharmaceuticals price target lowered to $3 from $4 at H.C. Wainwright
PremiumThe FlyRVL Pharmaceuticals price target lowered to $3 from $4 at H.C. Wainwright
1y ago
Cantor biotech/biopharma analysts to hold analyst/industry conference call
Premium
The Fly
Cantor biotech/biopharma analysts to hold analyst/industry conference call
1y ago
RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Premium
Press Releases
RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
1y ago
RVLP Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsRVLP Upcoming Earnings Report: What to Expect?
1y ago
Cantor biotech/biopharma analysts to hold analyst/industry conference call
Premium
The Fly
Cantor biotech/biopharma analysts to hold analyst/industry conference call
1y ago
RVL Pharmaceuticals plc to Discuss Second Quarter 2023 Financial Results and Provide Commercial Update
Premium
Press Releases
RVL Pharmaceuticals plc to Discuss Second Quarter 2023 Financial Results and Provide Commercial Update
1y ago
RVL Pharmaceuticals plc Reports First Quarter 2023 Financial Results; Provides Commercial Update
PremiumPress ReleasesRVL Pharmaceuticals plc Reports First Quarter 2023 Financial Results; Provides Commercial Update
1y ago
RVLP Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
RVLP Earnings this Week: How Will it Perform?
1y ago
RVL Pharmaceuticals plc to Discuss First Quarter 2023 Financial Results and Provide Commercial Update
Premium
Press Releases
RVL Pharmaceuticals plc to Discuss First Quarter 2023 Financial Results and Provide Commercial Update
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100